Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.
Press releases published on August 1, 2025
NordVPN launches Scam Call Protection feature for Android users in the US
GlobeNewswire
·
August 1, 2025
LONDON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Cybersecurity company NordVPN is rolling out a Scam Call Protection feature for Android users in the United States, giving people a new way to spot and dodge fraudulent calls and stay one step ahead of …
Ocugen Provides Business Update with Second Quarter 2025 Financial Results
GlobeNewswire
·
August 1, 2025
Conference Call and Webcast Today at 8:30 a.m. ET Initiated dosing in OCU410ST Phase 2/3 GARDian3 pivotal confirmatory clinical trial Actively dosing patients in OCU400 Phase 3 liMeliGhT clinical trial and on track for 2026 BLA filing OrthoCellix reverse …
OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case
GlobeNewswire
·
August 1, 2025
WARSAW, Ind., Aug. 01, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the US launch and first surgical case …
Bridger Aerospace Announces Schedule for its Second Quarter 2025 Earnings Release and Conference Call
GlobeNewswire
·
August 1, 2025
BELGRADE, Mont., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today announced that it will release financial …
I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares
GlobeNewswire
·
August 1, 2025
ROCKVILLE, Md., Aug. 01, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced the pricing of an …
Travel eSIM app Saily debuts Ultra, a new premium plan for unparalleled journeys
GlobeNewswire
·
August 1, 2025
LONDON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NordVPN’s travel eSIM app Saily is launching a premium subscription plan, Saily Ultra, which offers unlimited global eSIM data combined with special benefits for travelers. “The Saily Ultra plan is designed for …
Aemetis to Review Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire
·
August 1, 2025
CUPERTINO, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its second quarter 2025 earnings report: Date: Thursday, August 7, 2025 Time: 11 am Pacific …
Ascentage Pharma to Participate in Evercore China Biotech Summit
GlobeNewswire
·
August 1, 2025
ROCKVILLE, Md. and SUZHOU, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in …
Greif to Close Steel and Polymer Facility in Merced, California
GlobeNewswire
·
August 1, 2025
DELAWARE, Ohio, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Greif (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today it will permanently close the steel and polymer drum facility in Merced, California as part of its …
Cemtrex Issues Shareholder Update Highlighting Growth Across Vicon and AIS Divisions, Strategic Initiatives in Blockchain and Automation
GlobeNewswire
·
August 1, 2025
Hauppauge, NY, Aug. 01, 2025 (GLOBE NEWSWIRE) -- – Cemtrex Inc. (Nasdaq: CETX), a technology company focused on intelligent security and industrial services, today issued a shareholder update from Chairman and CEO Saagar Govil outlining the Company’s …
Viasat Comments on Letter from Carronade Capital Management
GlobeNewswire
·
August 1, 2025
CARLSBAD, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ:VSAT) (“Viasat” or “the Company”), a global leader in satellite communications, today issued the following statement in response to a letter from Carronade Capital Management. "Viasat …
Orchestra BioMed Announces Pricing of $40 Million Public Offering
GlobeNewswire
·
August 1, 2025
NEW HOPE, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced …
FOXO TECHNOLOGIES INC.’S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES
GlobeNewswire
·
August 1, 2025
WEST PALM BEACH, FLORIDA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its critical access designated rural hospital, Big South Fork Medical Center located in Oneida, …
IES Holdings Reports Fiscal 2025 Third Quarter Results
GlobeNewswire
·
August 1, 2025
HOUSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial results for the quarter ended June 30, 2025. Third Quarter 2025 Highlights and Recent Developments Revenue of $890 million …
Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company’s Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of Anxiety and Depression
GlobeNewswire
·
August 1, 2025
SOLANA BEACH, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (“Artelo” or the “Company”) (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with …
Aptose Selects Ernst & Young Global Limited as its New Independent Auditor and Calls Reconvened Meeting of its Shareholders
GlobeNewswire
·
August 1, 2025
SAN DIEGO and TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF; OTCQB: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy …
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on August 1, 2025, it awarded …
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
CLEVELAND, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule …
NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases
GlobeNewswire
·
August 1, 2025
MOUNTAIN VIEW, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical technology company focused on transforming the lives of people living with epilepsy, today issued the following statement in response to the Centers for …
TransAlta Reports Strong Second Quarter 2025 Results, Advancement of Strategic Priorities and Reaffirms Guidance
GlobeNewswire
·
August 1, 2025
CALGARY, Alberta, Aug. 01, 2025 (GLOBE NEWSWIRE) -- TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) today reported its financial results for the second quarter ended June 30, 2025. “Our strong second quarter results illustrate the …